This update serves to correct the reported net loss and clarify Proteome Sciences' expectation that protein biomarkers may be used to accelerate drug development and reduce costs.
NEW YORK (GenomeWeb News) - Proteome Sciences said full-year 2005 net losses increased 3.7 percent to £4.17 million ($7.7 million) from £4.02 million year over year.
The preliminary year-end report, released yesterday, also showed that total revenue slumped more than 77 percent to £16,200 from £73,000 a year ago.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

360Dx reports that the US Centers for Medicare & Medicaid Services would cover next-generation sequencing-based cancer panel tests.

The Washington Post reports that a meteorologist is being considered as presidential science and technology advisor.

In PNAS this week: precision medicine strategy to screen for disease risk, genome evolution in Haemophilus influenzae, and more.

Researchers have developed a PCR-based assay to gauge whether manatees are present in waters.